Month: February 2026

Xtract One Announces Fiscal 2026 Second Quarter Conference Call

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that it will release fiscal 2026 second quarter results after the close of trading on March 4, 2026. Peter Evans, Xtract One CEO and Director, and Karen Hersh, CFO and Corporate Secretary, will host a webcast and conference call at 10:00 a.m. Eastern Time the following day, March 5, 2026, to review financial results for the three months ended January 31, 2026. The webcast and presentation will be accessible on the Company’s website, and the telephone number for the conference call is 844-481-3016 (412-317-1881 for international callers). Management...

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

Written by Customer Service on February 17, 2026. Posted in Mergers And Acquisitions.

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertension Acquisition reinforces Essential Pharma’s mission to serve the needs of rare disease populations and enhances reputation as a trusted partner for continued access to niche medicinesEgham, UK – 17 February 2026 – Essential Pharma (“Essential” or “the Company”), a global specialty pharmaceutical company, today announces the acquisition of Ventavis® (iloprost trometamol) from Bayer AG, including rights to the accompanying Breelib® nebuliser delivery technology. The acquisition represents a significant milestone as Essential Pharma continues to grow its specialty rare disease franchise, reinforcing the Company’s mission to deliver medicines for small, underserved or rare disease populations globally. Ventavis®, a prostacyclin analogue,...

Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

$107.1 million in 4Q VYJUVEK revenue and $730.3 million since U.S. launch FDA granted RMAT to KB707 for the treatment of advanced NSCLC and Fast Track Designation to KB111 for the treatment of HHD Strong balance sheet, ending the quarter with $955.9 million in cash and investments PITTSBURGH, Feb. 17, 2026 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the fourth quarter and full year ending December 31, 2025 and provided a business update. “In 2025, Krystal made meaningful progress on our mission to serve patients with dystrophic epidermolysis bullosa around the world, while continuing to build the global infrastructure required to scale our impact,” said Krish S. Krishnan, Chairman and CEO of Krystal Biotech. “As we work toward our goal of launching multiple products...

Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

NEW HAVEN, Conn., Feb. 17, 2026 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review fourth quarter and full year 2025 financial results and provide a corporate update during a live webcast on Tuesday, February 24, 2026 at 8:00 a.m. ET. The webcast can be accessed under “Events and Presentations” on the investor page of the Arvinas website. A replay of the webcast will be available on the Arvinas website at www.arvinas.com following the completion of the event. About Arvinas Arvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. Through its PROTAC (PROteolysis TArgeting...

eToro Reports Fourth Quarter and Full Year 2025 Results

Written by Customer Service on February 17, 2026. Posted in Earnings Releases And Operating Results.

Record Net Contribution of $868 million, up 10% year-over-year, including $227 million in Q4 Q4 Assets Under Administration grew by 11% year-over-year to $18.5 billionAnnounced $100 million increase to share repurchase program NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced financial results for the fourth quarter and full year 2025 which ended December 31, 2025. “This was a milestone year for eToro,” said Yoni Assia, CEO of eToro. “We became a publicly traded company and significantly advanced the build-out of our global financial super-app. In 2025, we accelerated product innovation and AI adoption, expanded access to global markets, broadened and localized our offering, and strengthened eToro’s footprint around the world. We...

SAIC Announces CEO Appointment

Written by Customer Service on February 17, 2026. Posted in Public Companies.

Interim CEO, Former Board Member, and Seasoned Government Services Executive James Reagan Named CEO RESTON, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) — Science Applications International Corporation (Nasdaq: SAIC), a premier Fortune 500® company driving our nation’s digital transformation across the defense, space, civilian, and intelligence markets, today announced that the Company’s Board of Directors has appointed James (“Jim”) Reagan, Chief Executive Officer, effective immediately. “Following a thorough search process, the selection of Jim Reagan as CEO was a unanimous decision by the Board,” said SAIC Board Chair Donna Morea. “Over the past few months, Jim has proven to be the steady hand at the tiller SAIC needs. He understands the Company’s strengths and opportunities and has been working with SAIC business leaders to drive...

CorVel Earns Sixth Consecutive Great Place To Work® Certification™, Reflecting Continued Investment in Employees and Innovation

Written by Customer Service on February 17, 2026. Posted in Public Companies.

FORT WORTH, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL) is proud to be Certified™ by Great Place To Work® for the sixth consecutive year, an honor based entirely on employee feedback regarding their experience working at CorVel. The certification reflects the company’s focus on creating a workplace where employees feel supported, empowered, and equipped to do their best work. This year, employees recognized the company’s forward-looking approach and emphasized the importance of investing in technology, automation, and workflow tools to improve efficiency and service quality. CorVel received a high innovation score, reinforcing that innovation is an active and valued part of the company’s culture. Employees further described CorVel’s culture as welcoming, inclusive, and collaborative, and expressed...

DBGI Announces Extension of Warrant Exercise Period

Written by Customer Service on February 17, 2026. Posted in Public Companies.

Austin, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (“DBG” or the “Company”) (Ticker: [NASDAQ:DBGI]), a publicly traded company specializing in eCommerce and Fashion, today announced that it has entered into letter agreements (the “Agreements”) with certain existing holders (the “Holders”) of Common Share Purchase Warrants (the “Existing Warrants”) previously issued by the Company in an offering pursuant to that certain Registration Statement Form S-1 declared effective on February 11, 2025 (File No.: 333-284508). The Existing Warrants are scheduled to expire on February 17, 2026, and have an exercise price of $0.66 per share. Pursuant to the Agreement, each Holder agreed to exercise (i) 591,492 of its Existing Warrants at an exercise price of $0.66 per share upon entry into the Agreement and (ii) 2,408,508...

FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion

Written by Customer Service on February 17, 2026. Posted in Public Companies.

COMPANY ANNOUNCEMENT NO. 11-2026FLSmidth & Co. A/S17 February 2026Copenhagen, DenmarkFLSmidth & Co. A/S (“FLSmidth”) today announces the intention to initiate a new share buy-back programme of up to DKK 1.0 billion after the release of its Q1 2026 financial results. The company’s intention to initiate a share buy-back programme is supported by a solid balance sheet, sound cash-flow generation and the expected net cash proceeds from the sale of the company’s former corporate headquarters totalling DKK 730 million (ref. Company Announcement no. 9-2025), expected to be received upon closing of the transaction at the end of the first quarter of 2026. While pursuing value-accretive investments remains an important strategic focus point for FLSmidth, the company continues to prudently balance additional investments in growth with...

Crane NXT Announces Live Webcast of 2026 Investor Day

Written by Customer Service on February 17, 2026. Posted in Public Companies.

WALTHAM, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, announced that it will webcast its 2026 Investor Day presentations from 8:30 a.m. to approximately 12:00 p.m. Eastern Time on Wednesday, February 25, 2026. Investors who have not yet registered and are interested in attending the event in New York City, should contact Matt Roache, Vice President, Investor Relations, for additional details. The event will feature presentations from the following members of Crane NXT’s management team:Aaron Saak, President and Chief Executive Officer Sam Keayes, Senior Vice President, Security and Authentication Technologies Michael Mahan, President, CPI Christina Cristiano, Senior Vice President, Chief Financial OfficerFollowing the presentations, in-person attendees will have...

Month: February 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals